Ocugen (OCGN) Interest & Investment Income (2016 - 2026)
Ocugen (OCGN) reported Interest & Investment Income of $100000.0 for Q1 2026, down 66.67% on a YoY basis from $300000.0 in Q1 2025, and down 18.03% quarter-over-quarter from $122000.0 in Q4 2025.
Ocugen (OCGN) Interest & Investment Income (2016 - 2026) Analysis & Trends
Ocugen has reported Interest & Investment Income for 9 years, with the latest figure at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 66.67% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at -$629000.0 (down 152.81% YoY), and the FY2025 full-year result was $922000.0, down 26.3% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $100000.0, down from $122000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $408000.0 in Q4 2024, with the low at -$1.1 million in Q2 2025.
- Historically, Interest & Investment Income has averaged $96000.0 across 3 years, with a median of $207000.0 in 2025.
- The largest YoY upside for Interest & Investment Income was 0.66% in 2025 against a maximum downside of 711.56% in 2025.
- Ocugen's Interest & Investment Income stood at $408000.0 in 2024, then tumbled by 70.1% to $122000.0 in 2025, then fell by 18.03% to $100000.0 in 2026.
- The last three Interest & Investment Income figures came in at $100000.0 (Q1 2026), $122000.0 (Q4 2025), and $207000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 122,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Dec 31, 2020 | 1,065.00 |
| Mar 31, 2020 | 119.00 |
| Dec 31, 2019 | 107.00 |
| Sep 30, 2019 | 136.00 |
| Jun 30, 2019 | 377.00 |
| Mar 31, 2019 | 594.00 |
| Dec 31, 2018 | 1,820.00 |
| Sep 30, 2018 | 3,762.00 |
| Jun 30, 2018 | 32,000.00 |